Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort study

Abstract

Background Emergency admissions for infection often lack initial diagnostic certainty. COVID-19 has highlighted a need for novel diagnostic approaches to indicate likelihood of viral infection in a pandemic setting. We aimed to derive and validate a blood transcriptional signature to detect viral infections, including COVID-19, among adults with suspected infection who presented to the emergency department. Methods Individuals (aged ≥18 years) presenting with suspected infection to an emergency department at a major teaching hospital in the UK were prospectively recruited as part of the Bioresource in Adult Infectious Diseases (BioAID) discovery cohort. Whole-blood RNA sequencing was done on samples from participants with subsequently confirmed viral, bacterial, or no infection diagnoses. Differentially expressed host genes that met additional filtering criteria were subjected to feature selection to derive the most parsimonious discriminating signature. We validated the signature via RT-qPCR in a prospective validation cohort of participants who presented to an emergency department with undifferentiated fever, and a second case-control validation cohort of emergency department participants with PCR-positive COVID-19 or bacterial infection. We assessed signature performance by calculating the area under receiver operating characteristic curves (AUROCs), sensitivities, and specificities. Findings A three-gene transcript signature, comprising HERC6, IGF1R , and NAGK , was derived from the discovery cohort of 56 participants with bacterial infections and 27 with viral infections. In the validation cohort of 200 participants, the signature differentiated bacterial from viral infections with an AUROC of 0·976 (95% CI 0·919−1·000), sensitivity of 97·3% (85·8−99·9), and specificity of 100% (63·1−100). The AUROC for C-reactive protein (CRP) was 0·833 (0·694−0·944) and for leukocyte count was 0·938 (0·840−0·986). The signature achieved higher net benefit in decision curve analysis than either CRP or leukocyte count for discriminating viral infections from all other infections. In the second validation analysis, which included SARS-CoV-2-positive participants, the signature discriminated 35 bacterial infections from 34 SARS-CoV-2-positive COVID-19 infections with AUROC of 0·953 (0·893−0·992), sensitivity 88·6%, and specificity of 94·1%. Interpretation This novel three-gene signature discriminates viral infections, including COVID-19, from other emergency infection presentations in adults, outperforming both leukocyte count and CRP, thus potentially providing substantial clinical utility in managing acute presentations with infection. Funding National Institute for Health Research, Medical Research Council, Wellcome Trust, and EU-FP7.

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?

“…There has been speculation that some people may have been exposed to SARS-CoV-2 on multiple occasions but without this leaving any footprint of adaptive priming because of the efficiency of innate immune mechanisms. For example, longitudinal studies of a cohort of health-care workers showed that some heavily exposed but consistently PCR- and antibody-negative individuals have a raised frequency of memory T cells that are specific for epitopes from the SARS-CoV-2 replication transcription complex, as well as low-level activation of IFI2, an early marker of innate viral recognition 45 , 46 . Such ‘neutralizing’ effector pathways will remain hard to validate until more insight is gained from human challenge studies.…”

CompCorona: A Web Portal for Comparative Analysis of the Host Transcriptome of PBMC and Lung SARS-CoV-2, SARS-CoV, and MERS-CoV

“…When HERC6 is overexpressed, it promotes the inflammatory response (Cao et al, 2022;Scott et al, 2022). It has been mentioned that this gene is overexpressed in SARS-CoV-2 infection patients (Li et al, 2021). Human EXOG (hEXOG) is a 5′exonuclease crucial for mitochondrial DNA repair; The enzyme belongs to a family of nonspecific nucleases that includes the apoptotic endonuclease EndoG, and the accumulation of certain types of mitochondrial damage in its absence can directly trigger cell death (Van Houten et al, 2016;Szymanski et al, 2017).…”

Implications of Using Host Response-Based Molecular Diagnostics on the Management of Bacterial and Viral Infections: A Review

“…SARS-CoV-2 is the causative respiratory viral pathogen responsible for the COVID-19 (32). Given the need for rapid diagnostics, multiple studies explored the use of host-based (23).…”